CAH vs STEK
Cardinal Health Inc. and Stemtech Corp., side by side — 6 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | CAH | STEK |
|---|---|---|
| Revenue | $254.2B | $2.9M |
| Net income | $1.7B | $-4.0M |
| Gross margin | 3.8% | 80.3% |
| Net margin | 0.7% | −140.8% |
| Return on equity | · | · |
| Diluted EPS | $7.23 | −$0.02 |
| Dividend / share | $2.04 | · |
| Payout ratio | 28.6% | · |
| Free cash flow | $4.5B | $-483,583 |
| Equity | $-2.9B | $-7.0M |
| Net debt / equity | · | · |
| Current ratio | 0.88× | 0.04× |
| Revenue CAGR 5y | 9.4% | −8.1% |
| Profit CAGR 5y | 22.9% | · |
CAH bills 88391.7× the revenue of STEK, and STEK closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
6 years side by side
| Fiscal year | CAH | STEK |
|---|---|---|
| FY2025 | $254.2B | $2.9M |
| FY2024 | $222.6B | $5.1M |
| FY2023 | $226.8B | $4.9M |
| FY2022 | $205.0B | $4.6M |
| FY2021 | $181.3B | $4.3M |
| FY2020 | $162.5B | $4.4M |
Bottom line
| Fiscal year | CAH | STEK |
|---|---|---|
| FY2025 | $1.7B | $-4.0M |
| FY2024 | $1.6B | $-3.8M |
| FY2023 | $852.0M | $-5.4M |
| FY2022 | $330.0M | $-8.5M |
| FY2021 | $-938.0M | $-7.1M |
| FY2020 | $611.0M | $-916,697 |
6 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$254,245,123,620 | CAH |
| FY2024 | +$222,572,946,310 | CAH |
| FY2023 | +$226,822,078,469 | CAH |
| FY2022 | +$204,974,440,601 | CAH |
| FY2021 | +$181,321,678,755 | CAH |
| FY2020 | +$162,462,615,493 | CAH |
CAH has reported the higher revenue in every one of these 6 fiscal years. The gap has widened since the earliest year compared.
6 of 19 comparable fiscal years — a year missing data on either side is not counted.
6 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +141.5 pp | CAH |
| FY2024 | +75.4 pp | CAH |
| FY2023 | +110.7 pp | CAH |
| FY2022 | +189.5 pp | CAH |
| FY2021 | +164.0 pp | CAH |
| FY2020 | +39.8 pp | CAH |
CAH has kept the higher net margin in every one of these 6 fiscal years.
6 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
STEK's net margin has been more volatile than CAH's over the 6 comparable fiscal years — 51.4 percentage points of standard deviation against 0.4.
6 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
CAH led in net margin in every one of the 6 comparable fiscal years — a structural lead, not a recent swing.
6 of 19 comparable fiscal years — a year missing data on either side is not counted.